Albenza
NDC Package 55695-021-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Albenza is a medication used to treat certain tapeworm infections (such as neurocysticercosis and hydatid disease). Marketed by Department Of State Health Services, Pharmacy Branch, this product is identified by NDC 55695-021 and is authorized under FDA application NDA020666.

Identification & Billing

NDC Package Code
55695-021-00
Package Description
2 TABLET, FILM COATED in 1 BOTTLE
Product Code
55695-021
11-Digit Billing Format
55695002100

Clinical Specifications

Proprietary Name
Albenza
Dosage Form
-
Usage Information
This medication is used to treat certain tapeworm infections (such as neurocysticercosis and hydatid disease).

Regulatory & Marketing

Labeler Name
Department Of State Health Services, Pharmacy Branch
FDA Application #
NDA020666
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-11-1996
End Marketing Date
09-30-2019
Listing Expiration
09-30-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55695-021-00 identifies a specific commercial package of 2 tablet, film coated in 1 bottle of Albenza, labeled by Department Of State Health Services, Pharmacy Branch. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Department Of State Health Services, Pharmacy Branch on June 11, 1996. The current certification is valid through September 30, 2019.

What are the primary indications for this medication?

This medication is used to treat certain tapeworm infections (such as neurocysticercosis and hydatid disease).

How is this Department Of State Health Services, Pharmacy Branch product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55695002100. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55695-021-00
11-Digit CMS (5-4-2)
55695-0021-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.